Skip to main content


No CLEARity about antithrombotic around endovascular treatment

Antithrombotic regimes around peripheral vascular interventions are currently mostly based on individual beliefs and some secondary data from studies with different endpoints. The problem is that antithrombotic regimes have several goals to meet; to prevent acute thrombotic complications, to prevent intimal hyperplasia to obtain better TLR, and to achieve secondary risk prevention for vascular disease in general. The latter is scientifically proven in large studies. The use of some sort of antithrombotic treatment is not disputed, but there is no uniformity and no scientific guidelines in peripheral arterial interventions. The CLEAR survey by Christopher Twine et al. is a call to start a large study to solve this problem.

15% APC discount for CIRSE Members

To celebrate CVIR Endovascular's success, help reduce the financial costs for authors and encourage more CIRSE researchers to consider publishing open access, the Cardiovascular and Interventional Radiology Society of Europe (CIRSE) now offers a 15% discount on the APC for CVIR Endovascular to corresponding authors who are CIRSE members in good standing. In order to apply for this discount, please contact CVIR Endovascular’s editorial team at before submitting your paper.

Please note that the CIRSE discount cannot be combined with an institutional discount.


CVIR Endovascular supports the open discussion and review of scientific articles post-publication. It is for this reason that we encourage the use of the comments feature, which can be found at the bottom of each article page.

Trending Articles

Click here to view which articles in CVIR Endovascular have been shared the most!

Aims and scope

CVIR Endovascular is a multidisciplinary open access journal of the Cardiovascular and Interventional Radiological Society of Europe and the first open peer review journal in the field of endovascular interventions. The journal is intended for ALL specialists working in the field of endovascular treatment. CVIR Endovascular publishes articles in the area of venous and arterial interventions including vascular malformations, non-oncological embolization, peripheral vascular interventions, aortic interventions, emergency medicine and carotid interventions. CVIR Endovascular publishes a range of article types including clinical investigations, systematic reviews, case reports, technical reports and video cases. The field of endovascular treatment is very dynamic and new ideas need rapid communication so that the latest information is available to treat our patients.  CVIR Endovascular also wants to stimulate scientific discussions and provides a podium to discuss your research work with your peers.

Latest Tweets

Sign up to receive article alerts

CVIR Endovascular is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering here.

Open Peer Review

Neuer Inhalt

CVIR Endovascular is the first open peer reviewed journal in the field of interventional radiology. It uses a highly transparent peer review model, in which the authors and the reviewers are aware of each other's identity. After a paper has been accepted for publication, the review reports and authors’ comments will be published together with the article and displayed for everyone to read and comment on.

Benefits of Open Peer Review:

- Transparency: sheds light on the black box of peer review
- Reviewers are credited for their report
- Reviewers & editors are fully (and publicly) accountable for their decisions
- Bias is reduced
- Increases of the quality of peer-review
- Provides an additional level of scientific discussion
- Educational aspect: provides teaching material for junior reviewers

Editor's Quote

Neuer Inhalt

Endovascular treatment is a multidisciplinary profession which is producing a constant stream of new technologies and scientific publications. Interventional radiologists, vascular surgeons, cardiologists and angiologists are all active in this field.

The developments in endovascular treatment are presented at an exceptional pace, whether that be through modifications of existing technologies or completely new pathways. Fast communication without borders and hurdles is therefore needed, and open access is the way forward.

Therefore, we created CVIR Endovascular as a platform to publish papers focused on endovascular treatment and to communicate to the endovascular community through a constant stream of publications.

Discussions among peers have been fundamental to the development of endovascular treatment. We would like to keep this tradition alive by opening a discussion platform for the whole endovascular community. 

The open access model of the journal will offer a fast and reliable way to disseminate knowledge and can be supported with several funding schemes in case authors are in need of resources for article publication.

A fast and effective open peer-review process, in line with the characteristics of the endovascular attitude, will ensure a rapid appraisal of manuscripts.

CVIR Endovascular seeks to facilitate an environment of engaging with, learning from, and questioning your peers, and we are confident CVIR Endovascular will actively contribute to creating a bridge between different modalities that are in charge of endovascular treatment and will facilitate their use in the scientific community.

New Content Item

Jim A Reekers, Editor in Chief


Affiliated with

Related Journal

Cardiovascular and Interventional Radiology

Neuer Inhalt

Annual Journal Metrics

  • Speed
    50 days to first decision for reviewed manuscripts only
    43 days to first decision for all manuscripts
    86 days from submission to acceptance
    68 days from acceptance to publication

    140 Altmetric Mentions

Need help with APC funding?

New Content Item

We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. ​​​​​​​Learn more here.

Check if your institution is a member

More than 500 institutions have partnered with BMC through the membership program. As an affiliated Author from a member institution, you may be entitled to submit your manuscript without paying the article processing charge (APC) or with a discount. Check here if your institution is a member!